Subtype
Large Intestinal Neoplasm
CI-CAN-00001062Explore in graph →
Non-malignant1,847 active trials21 approved drugs383 evidence items
- NCIt
- C215201
Loading cancer entity…
Subtype
CI-CAN-00001062Explore in graph →
Clinical trials
8,849 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06203587 | Clinical Study of GPA33-specific PET/CT for the Diagnosis of Colorectal Cancer | unknown | N/A | 40 | Huashan HospitalOTHER | 1 | Feb 20, 2024 | clinicaltrials |
| NCT03924466 | Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients(VUBAR) | unknown | Phase 2 | 55 | Universitair Ziekenhuis BrusselOTHER | 1 | Feb 16, 2024 | clinicaltrials |
| NCT06262581 | Neoadjuvant Tisleizumab(BGB-A317) for dMMR/MSI-H Non-late Stage CRC Patients Before Surgery | unknown | Phase 2 | 40 | Sun Yat-sen UniversityOTHER | 1 | Feb 16, 2024 | clinicaltrials |
| NCT06251726 | Personalized Medicine in Early Stage Colorectal Cancer: Organ Preservation and Immune Benefit(COLOSAVE) | unknown | — | 310 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Feb 15, 2024 | clinicaltrials |
| NCT02597348 | Liver Transplantation in Patients With Unresectable Colorectal Liver Metastases Treated by Chemotherapy(TRANSMET) | unknown | N/A | 94 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Feb 14, 2024 | clinicaltrials |
| NCT04145388 | Family History Study on Cancer Risk | unknown | N/A | 18,623 | Kaiser PermanenteOTHER | 1 | Feb 14, 2024 | clinicaltrials |
| NCT06258434 | Liquid Biopsy Based Multiomics Study for Colorectal Cancer Early Screening(COLO-LIMULOID) | unknown | — | 1,000 | Sir Run Run Shaw HospitalOTHER | 1 | Feb 14, 2024 | clinicaltrials |
| NCT04952688 | Modifications in Retinal Microvascularization With Targeted Anti-angiogenic Therapy in Colorectal Cancer(VOCANGIO) | unknown | N/A | 30 | Centre Georges Francois LeclercOTHER | 1 | Feb 13, 2024 | clinicaltrials |
| NCT06256315 | Hyper-ERAS Program for Highly Selective Colorectal Cancer Patients | unknown | N/A | 160 | Peking University Cancer Hospital & InstituteOTHER | 1 | Feb 13, 2024 | clinicaltrials |
| NCT05028933 | IMC001 for Clinical Research on Advanced Digestive System Malignancies | unknown | Phase 1 | 48 | Zhejiang UniversityOTHER | 1 | Feb 12, 2024 | clinicaltrials |
| NCT05213195 | NKG2D CAR-NK Cell Therapy in Patients With Refractory Metastatic Colorectal Cancer | unknown | Phase 1 | 38 | Zhejiang UniversityOTHER | 1 | Feb 12, 2024 | clinicaltrials |
| NCT06253949 | Compare Outcomes After High and Low Ligation of Inferior Mesenteric Artery in Colorectal Cancer | unknown | N/A | 50 | Sohag UniversityOTHER | 1 | Feb 12, 2024 | clinicaltrials |
| NCT05400408 | Chemical Profiling of Colorectal and Pancreatic Cancers Using Breath Analysis - Feasibility Study(Cancer) | unknown | N/A | 250 | Scentech Medical Technologies LtdINDUSTRY | 1 | Feb 7, 2024 | clinicaltrials |
| NCT05663788 | Web-based Learning Module on Optical Diagnosis of Early Colorectal Cancer(LODIP) | unknown | N/A | 166 | Althaia Xarxa Assistencial Universitària de ManresaOTHER | 4 | Feb 7, 2024 | clinicaltrials |
| NCT05980689 | Combination of AK104 and Neoadjuvant Chemoradiotherapy in pMMR/MSS Locally Advanced Rectal Cancer | unknown | Phase 2 | 33 | Sun Yat-sen UniversityOTHER | 1 | Feb 7, 2024 | clinicaltrials |
| NCT05933980 | Toripalimab,Celecoxib and Regorafenib in the Treatment of Refractory Advanced Colorectal Cancer(REGOTORICOX) | unknown | Phase 2 | 44 | Sun Yat-sen UniversityOTHER | 1 | Feb 6, 2024 | clinicaltrials |
| NCT00565708 | Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers(ASCOLT) | unknown | Phase 3 | 1,587 | National Cancer Centre, SingaporeOTHER | 10 | Feb 2, 2024 | clinicaltrials |
| NCT01515787 | PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery | unknown | Phase 2 / Phase 3 | 1,194 | Alliance for Clinical Trials in OncologyOTHER | 4 | Feb 2, 2024 | clinicaltrials |
| NCT05787535 | HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor | unknown | Phase 1 | 17 | HRYZ Biotech Co.INDUSTRY | 1 | Feb 2, 2024 | clinicaltrials |
| NCT06239870 | Single-arm, Single-center, Exploratory Phase II Clinical Study of Envafolimab Combined With Chemoradiotherapy in the Treatment of Locally Advanced pMMR/MSS Rectal Cancer(ESTIMATE) | unknown | Phase 2 | 35 | Yunnan Cancer HospitalOTHER | 1 | Feb 2, 2024 | clinicaltrials |
| NCT03799939 | Chimney Trial of Parastomal Hernia Prevention | unknown | N/A | 141 | University of OuluOTHER | 2 | Feb 1, 2024 | clinicaltrials |
| NCT05291156 | CAVE-2 GOIM Study: a Clinical Study of the Combination of Avelumab Plus Cetuximab as Rechallenge Strategy | unknown | Phase 2 | 173 | University of Campania Luigi VanvitelliOTHER | 1 | Feb 1, 2024 | clinicaltrials |
| NCT06236386 | Virtual Reality During Colonoscopy Procedures(VR) | unknown | N/A | 120 | University of Puerto RicoOTHER | 0 | Feb 1, 2024 | clinicaltrials |
| NCT03503630 | Short-course Radiation Followed by mFOLFOX-6 Plus COMPOUND 2055269 for Locally-advanced Rectal Adenocarcinoma | unknown | Phase 2 | 44 | Ali ShamseddineOTHER | 2 | Jan 31, 2024 | clinicaltrials |
| NCT06231017 | Adebrelimab Plus Cetuximab and Chemotherapy for Patients With RAS/BRAF Wild-Type Unresectable Liver Metastases Colorectal Cancer | unknown | Phase 2 | 36 | The First Affiliated Hospital of Zhengzhou UniversityOTHER | 1 | Jan 30, 2024 | clinicaltrials |
| NCT06231524 | Development and Validation of a PSN-AI Prediction Model(PSN-AI) | unknown | — | 50 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Jan 30, 2024 | clinicaltrials |
| NCT03872908 | Satisfaction & Efficacy of Compression Using Surgical Gloves in Chemo-induced Peripheral Neuropathies(ELEGANT) | unknown | — | 177 | Centre Leon BerardOTHER | 1 | Jan 25, 2024 | clinicaltrials |
| NCT06010901 | A Clinical Study of TQB2618 Injection Monotherapy and Combination Regimen (With Penpulimab Injection ±Anlotinib Hydrochloride Capsules) in the Four or Later Lines of Treatment of Advanced Colorectal Cancer. | unknown | Phase 1 | 75 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Jan 23, 2024 | clinicaltrials |
| NCT06218108 | Multicenter Observational Study Taulí-T1 Classification for the Management of pT1 Rectal Adenocarcinoma(TAUTEM-pT1) | unknown | — | 317 | Corporacion Parc TauliOTHER | 1 | Jan 23, 2024 | clinicaltrials |
| NCT06182644 | Head-to-head Comparison of Positron Nuclide Radio-labeled FAPI and 18F-FDG PET/CT in Patients With Malignant Tumors(FAPI) | unknown | N/A | 30 | Guangdong Provincial People's HospitalOTHER | 1 | Jan 22, 2024 | clinicaltrials |
| NCT06216834 | Quality of Life and Psychosocial Status of Young-onset Patients With Rectal Cancer | unknown | — | 300 | Shandong Provincial HospitalOTHER_GOV | 1 | Jan 22, 2024 | clinicaltrials |
| NCT05646043 | PREHAB - Improving Condition Before Surgery | unknown | N/A | 40 | University Hospital OstravaOTHER | 1 | Jan 18, 2024 | clinicaltrials |
| NCT05435313 | Fruquintinib Combined With Tislelizumab and HAIC in Patients With Advanced Colorectal Liver Metastases Cancer Who Failed Standard Therapy | unknown | Phase 2 | 39 | Fudan UniversityOTHER | 1 | Jan 17, 2024 | clinicaltrials |
| NCT04500392 | High-flow Nasal Cannula Oxygenation Decrease Hypoxia in Sedated Gastrointestinal Endoscopes in Obesity | unknown | N/A | 1,000 | RenJi HospitalOTHER | 1 | Jan 11, 2024 | clinicaltrials |
| NCT06200363 | A Clinical Study of T3011 in Combination With Regorafenib in Patients With Advanced Colorectal Cancer | unknown | Phase 1 | 15 | West China HospitalOTHER | 1 | Jan 11, 2024 | clinicaltrials |
| NCT06194786 | Diet and Physical Activity Program in Colorectal Cancer Survivor: a Randomized Controlled Trial(DPAP) | unknown | N/A | 260 | Habib Bourguiba University HospitalOTHER | 1 | Jan 9, 2024 | clinicaltrials |
| NCT05522738 | Safety and Efficacy of Fruquintinib+FOLFIRI in RAS-mutated Metastatic Colorectal Cancer | unknown | Phase 1 / Phase 2 | 46 | Chinese PLA General HospitalOTHER | 1 | Jan 8, 2024 | clinicaltrials |
| NCT06145230 | A Cross-sectional Survey of Colorectal Cancer Patients in Different Age Groups | unknown | — | 430 | Wang GuiyuOTHER | 1 | Jan 5, 2024 | clinicaltrials |
| NCT06171854 | caBozantinib in Pre-treated pAtients With Metastatic COlorectal Cancer.(ABACO) | unknown | Phase 2 | 33 | University of Campania Luigi VanvitelliOTHER | 1 | Jan 2, 2024 | clinicaltrials |
| NCT03034473 | Translational Validation Study to Examine KFO179-1 Biomarker Scores for the Prediction and Prognosis of Advanced Primary Resectable Rectal Cancer Stages UICC-II-IV, With a 5-Fluorouracil-based Standard Radiochemotherapy Followed by Total Mesorectal Excision.(TransValid-A) | unknown | N/A | 200 | University Medical Center GoettingenOTHER | 1 | Dec 28, 2023 | clinicaltrials |
| NCT04338191 | mFOLFOXIRI Versus mFOLFOX6 as Adjuvant Chemotherapy for Locally Advanced Colorectal Cancer(FANTASTIC) | unknown | Phase 3 | 638 | Sun Yat-sen UniversityOTHER | 1 | Dec 27, 2023 | clinicaltrials |
| NCT05631041 | Effect of Silymarin in Metastatic Colorectal Cancer Patients | unknown | Phase 3 | 64 | Tanta UniversityOTHER | 1 | Dec 22, 2023 | clinicaltrials |
| NCT02473003 | Physical Training and Cancer-a Multicenter Clinical Trial(Phys-Can) | unknown | N/A | 600 | Uppsala UniversityOTHER | 0 | Dec 21, 2023 | clinicaltrials |
| NCT01294072 | Study Investigating the Ability of Plant Exosomes to Deliver Curcumin to Normal and Colon Cancer Tissue | unknown | N/A | 35 | University of LouisvilleOTHER | 1 | Dec 20, 2023 | clinicaltrials |
| NCT06177288 | DEBIRI Combined With Chemotherapy and Bevacizumab in the Treatment of Unresectable Colorectal Cancer Liver Metastases(DEBIRI) | unknown | N/A | 39 | Fudan UniversityOTHER | 1 | Dec 20, 2023 | clinicaltrials |
| NCT06172647 | Mucosa Adherent Intestinal Microbiome in Microscopic Colitis and Colorectal Cancer(CMBACT) | unknown | — | 60 | Hospital Mutua de TerrassaOTHER | 1 | Dec 15, 2023 | clinicaltrials |
| NCT04264702 | BESPOKE Study of ctDNA Guided Therapy in Colorectal Cancer | unknown | — | 1,788 | Natera, Inc.INDUSTRY | 1 | Dec 12, 2023 | clinicaltrials |
| NCT01477229 | Quality of Life in RECTal Cancer - a Prospective Multicenter Cohort Study(QoLiRECT) | unknown | — | 1,500 | Sahlgrenska University HospitalOTHER | 1 | Dec 8, 2023 | clinicaltrials |
| NCT02546973 | Quality of Life in Patients With Anal Cancer(ANCA) | unknown | — | 300 | Sahlgrenska University HospitalOTHER | 1 | Dec 8, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Feb 20, 2024source: clinicaltrials